Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer

Published:2008-05 Issue:2 Volume:60 Page:222-230
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Timmer-Bonte J.N.H.,Punt C.J.A.,vd Heijden H.F.M.,van Die C.E.,Bussink J.,Beijnen J.H.,Huitema A.D.R.,Tjan-Heijnen V.C.G.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials;Hotta;Ann Oncol,2004

2. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis;Delbaldo;JAMA,2004

3. The importance of chemotherapy dose intensity in lung cancer;Crawford;Semin Oncol,2004

4. Chemotherapy in advanced nonsmall cell lung cancer: indication, intensity, and duration;Booton;Curr Opin Oncol,2002

5. Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors;Timmer-Bonte;Anticancer Drugs,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea;Supportive Care in Cancer;2021-03-08

2. Clinical Applications of Nanosized Drug-Delivery Systems in Lung Cancer Imaging and Therapy;Critical Reviews™ in Therapeutic Drug Carrier Systems;2020

3. A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer;Frontiers in Oncology;2019-04-26

4. Immune Therapy;Lung Cancer and Personalized Medicine;2015-12-15

5. Immunotherapy prospects in the treatment of lung cancer and mesothelioma;TRANSL LUNG CANCER R;2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3